Inflammation, joints and pain
What human research has studied for osteoarthritis, joint pain and inflammatory markers, across every ingredient in this guide, strongest evidence first. A grade describes the evidence, not a recommendation.
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. Ask a doctor or pharmacist before use, especially with medicines, in pregnancy or for a child.
How strong the evidence is
Where inflammation, joints and pain sits on the supplement body map; colored by its strongest grade here.
Findings by ingredient
| Ingredient | Grade | What was studied and found |
|---|---|---|
| Boswellia | B | Knee and other osteoarthritis pain and function. Cochrane: two high-quality trials (85 people) of 100 mg/day enriched extract for 90 days cut pain by 17 points (0–100 scale) and improved function by 8 points versus placebo. sources |
| Bromelain | B | Pain and recovery after wisdom tooth (third molar) surgery. A 2019 meta-analysis (6 RCTs) found less pain in the first 24 hours and at 7 days and better quality-of-life scores, but no evidence that bromelain reduced trismus or facial swelling. sources |
| Collagen peptides | B | Knee osteoarthritis pain and function. A 2025 meta-analysis of 11 RCTs (870 participants) found improved pain and function scores versus placebo, with high heterogeneity between trials (I² 75% and 88%). sources |
| Devil's claw | B | Non-specific low back pain in adults. A Cochrane review found that daily extracts standardized to 50 mg or 100 mg harpagoside may beat placebo for short-term pain and rescue-medication use (two trials, 315 participants, low-quality evidence). sources |
| GLA oils (borage and blackcurrant seed oil) | B | Rheumatoid arthritis pain and disability. A 2011 Cochrane review pooled 7 studies of GLA from evening primrose, borage or blackcurrant seed oil: lower pain intensity (-32.83 points, 100-point scale) and less disability; authors judged the evidence moderate. sources |
| Hesperidin | B | Inflammation and oxidative stress markers. A 2026 meta-analysis of 10 RCTs (532 participants) found lower C-reactive protein (SMD -0.43) and TNF-α (SMD -0.51), but no significant effect on IL-6 overall. sources |
| MSM (methylsulfonylmethane) | B | Knee osteoarthritis pain and function. A 2018 meta-analysis of placebo-controlled RCTs of oral supplements found statistically significant improvements in osteoarthritis pain with MSM, but of unclear clinical importance. sources |
| N-acetylcysteine (NAC) | B | Inflammatory markers in adults. A 2020 meta-analysis of 24 RCTs (1,057 participants; 400–2000 mg/day for 1–80 weeks) found oral NAC lowered CRP (−0.61 mg/L) and IL-6, with high heterogeneity; other inflammatory markers did not change. sources |
| Palmitoylethanolamide (PEA) | B | Chronic pain. A 2023 meta-analysis of 11 double-blind RCTs (774 patients; 4 tested PEA with transpolydatin) found lower pain scores than comparators (SMD 1.68); no major side effects were attributed to PEA. sources |
| Palmitoylethanolamide (PEA) | B | Acute or chronic pain versus inactive control. A 2017 meta-analysis pooled 8 RCTs with inactive controls and found greater pain reduction with PEA; the authors note few trials, varied conditions and often poor study quality. sources |
| Rose hip | B | Osteoarthritis pain. A 2008 meta-analysis of three placebo-controlled RCTs (287 patients, median 3 months) found reduced pain (effect size 0.37), with patients about twice as likely to respond (OR 2.19); all trials were manufacturer-supported, and independent replication was called for. sources |
| Turmeric (and curcumin) | B | Knee osteoarthritis pain and function (oral). Several meta-analyses evaluated oral turmeric or curcumin; NCCIH calls the initial evidence positive but says higher-quality evidence is needed for definitive conclusions. sources |
| Undenatured type II collagen | B | Knee osteoarthritis pain and function. A 2023 review of 8 RCTs (3–6 months) pooled 6 for WOMAC (MD -8.91) and 3 for VAS pain (MD -1.65), both favoring the collagen over placebo or control; Lequesne index did not differ. Authors call for larger trials. sources |
| Undenatured type II collagen | B | Knee osteoarthritis (180-day trial versus placebo and glucosamine-chondroitin). In an RCT of 191 volunteers, 40 mg/day for 180 days reduced total WOMAC score versus placebo (p = 0.002) and versus glucosamine plus chondroitin (p = 0.04); safety outcomes did not differ among groups. sources |
| Undenatured type II collagen | B | Osteoarthritis pain across supplements (meta-analysis). A 2018 meta-analysis of 69 placebo-controlled RCTs of 20 supplements found only green-lipped mussel extract and undenatured type II collagen had clinically important effects on pain at medium term. sources |
| Andrographis | C | Rheumatoid arthritis symptoms. Small trials suggested reduced rheumatoid factors and arthritis symptoms; MSK states additional studies are needed to confirm these effects. sources |
| Argan oil | C | Knee osteoarthritis symptoms. In one randomized trial of 100 patients with knee osteoarthritis, 30 ml/day of culinary argan oil for 8 weeks improved pain, function and walking distance versus no treatment; there was no placebo. sources |
| Arnica | C | Hand osteoarthritis pain (gel on the skin). In a double-blind RCT of 204 patients over 21 days, an arnica gel (50 g tincture/100 g) was not inferior to 5% ibuprofen gel for pain and hand function. sources |
| Arnica | C | Pain and inflammation (overall evidence). LiverTox states there is little evidence for efficacy of either oral homeopathic or topical herbal arnica, and clinical studies have not confirmed its effects on inflammation or pain. sources |
| Aronia (black chokeberry) | C | Inflammation markers and antioxidant enzymes. A 2025 systematic review of 18 studies (aronia juice, extract or powder for 4 to 13 weeks) reported lower CRP, TNF-alpha and IL-6, higher IL-10 and higher antioxidant enzyme activity. sources |
| Açaí | C | Metabolic syndrome biomarkers. A 12-week double-blind trial in 37 adults with metabolic syndrome lowered two markers of inflammation and oxidative stress versus placebo, with no change in glucose or lipid metabolism; authors called it a weak indication. sources |
| Bacillus coagulans (Heyndrickxia coagulans) | C | Rheumatoid arthritis, alongside standard medication (strain GBI-30, 6086). In a pilot RCT of 45 adults, 60 days of GBI-30, 6086 gave a borderline improvement in patient pain assessment (P = .052) and a significant pain-scale improvement versus placebo; authors call for larger trials. sources |
| Baikal skullcap | C | Osteoarthritis symptoms (multi-ingredient supplement). MSK reports that an herbal supplement containing S. baicalensis reduced osteoarthritis symptoms, but it is not known whether the herb alone would have similar effects. sources |
| Betaine (trimethylglycine) | C | Inflammatory markers. A 2023 meta-analysis of 6 RCTs (277 participants) found a slight reduction in IL-1β with high heterogeneity and no significant change in CRP, IL-6 or TNF-α; the authors found insufficient evidence. sources |
| Boron | C | Osteoarthritis symptoms. Small trials (20–60 participants, 2–8 weeks, 1.5–12 mg/day) reported reduced symptoms or inflammatory markers; ODS says confirmation is needed from additional controlled trials. sources |
| BPC-157 | C | Chronic knee pain (injection into the joint). In a retrospective study of intra-articular BPC-157 injection for knee pain, 7 of 12 patients reported relief for more than 6 months; the 2025 review rated the available studies level IV and V evidence. sources |
| Bromelain | C | Pain (oral bromelain across conditions). A 2023 meta-analysis found pain reduction from oral bromelain slightly but significantly better than controls (mean difference -0.27; 9 studies); bromelain was not effective for cardiovascular diseases. sources |
| Carnosine (L-carnosine) | C | Inflammation and oxidative stress markers. A 2024 meta-analysis of 9 trials (350 participants) of carnosine or other histidine-containing dipeptides found lower CRP, TNF-α and MDA but no effect on IL-6, adiponectin, GSH, SOD or TAC. sources |
| Cat's claw | C | Rheumatoid arthritis (adults also taking sulfasalazine or hydroxychloroquine). A 24-week placebo-controlled trial in 40 patients found fewer painful joints with a pentacyclic-chemotype extract (53.2% vs 24.1% reduction); the authors called it a small preliminary study. sources |
| Cat's claw | C | Knee osteoarthritis (Uncaria guianensis). A 4-week trial in 45 patients (30 freeze-dried U. guianensis, 15 placebo) reported less pain with activity; knee pain at rest or at night did not change significantly. sources |
| Devil's claw | C | Knee and hip osteoarthritis. In a 4-month double-blind trial of 122 patients, powdered root was comparable to diacerhein 100 mg/day for pain and function, with less diarrhea; there was no placebo group. sources |
| Devil's claw | C | Osteoarthritis and back pain (systematic review). A 2004 review of 12 trials could not pool data; it rated evidence limited for low-harpagoside ethanolic extracts and moderate for powder at 60 mg harpagoside in osteoarthritis. sources |
| Ginger | C | Knee osteoarthritis symptoms. Oral supplements might help, but much of the research is of poor quality; topical ginger has not been shown to help. sources |
| Glucosamine and chondroitin | C | Knee osteoarthritis pain and function. A 2018 analysis of 29 studies (6,120 participants) found pain reduced by glucosamine or chondroitin alone but not by the combination; individual studies were inconsistent, and NCCIH calls the benefit uncertain. sources |
| Glucosamine and chondroitin | C | Joint structure (joint-space narrowing) in knee osteoarthritis. Two large 2-year trials conflicted: an Australian trial (605 participants) found less narrowing with the combination; a US trial (572 participants) found no difference from placebo. sources |
| Glucosamine and chondroitin | C | Hand osteoarthritis (chondroitin). One 6-month study in 162 participants found less hand pain and better function with chondroitin than placebo. sources |
| Glucosamine and chondroitin | C | Temporomandibular joint osteoarthritis (glucosamine). A review of 8 studies (538 participants) could not reach definite conclusions; studies differed in methods and products and some may have been biased. sources |
| Haritaki | C | Knee joint discomfort with activity in overweight adults. An 84-day RCT in 105 overweight, otherwise healthy adults found a standardized aqueous fruit extract (250 or 500 mg twice daily) improved knee-joint scores (mKOOS global) versus placebo. sources |
| Hyaluronic acid (oral) | C | Osteoarthritis and low back pain. A 2024 systematic review of 11 trials (597 patients) found improvement in 9; only 2 trials gave oral hyaluronic acid alone, while 9 combined it with substances such as glucosamine, chondroitin or collagen. sources |
| Krill oil | C | Knee pain, stiffness and function. A 2024 meta-analysis (5 RCTs, 700 patients) found no significant difference from placebo for knee pain, stiffness or lipids, and a small improvement in knee physical function (SMD -0.24). sources |
| MSM (methylsulfonylmethane) | C | Knee pain during military training. In an RCT of 180 military trainees, 3 g/day for 8 weeks did not significantly improve knee outcome or mood scores versus placebo. sources |
| MSM (methylsulfonylmethane) | C | Mild knee pain in healthy adults. In an RCT of 88 healthy Japanese adults with mild knee pain, 2 g/day (ten 200 mg tablets) for 12 weeks improved a knee quality-of-life score versus placebo (p = 0.046). sources |
| Perilla | C | Extract (var. frutescens): mild knee joint pain. In an 8-week RCT of 80 adults without radiographic arthritis, a 700 mg extract capsule twice daily reduced pain and WOMAC scores more than placebo; inflammation markers did not change. sources |
| Propolis | C | Rheumatoid arthritis disease activity. MSK reports that a double-blind RCT of Brazilian propolis found no benefit for rheumatoid arthritis. sources |
| Rose hip | C | Knee function during walking. In one 12-week RCT of 100 adults with knee-related walking limitations, rose hip powder capsules improved the peak resultant knee moment during walking versus placebo (0.06 Nm/kg). sources |
| Rose hip | C | Rheumatoid arthritis. In one 6-month RCT of 89 patients, 5 g/day rose hip powder improved a disability score (HAQ-DI) versus placebo; pain scores and pain-medication use did not differ. sources |
| SAMe (S-adenosyl-L-methionine) | C | Osteoarthritis of the knee or hip. A 2009 Cochrane review (4 placebo-controlled trials, 656 patients) found a small, non-significant pain difference (0.4 cm on a 10 cm scale), called the evidence inconclusive and advised against routine use. sources |
| Serrapeptase | C | Trismus, swelling and pain after impacted molar surgery. A 2018 meta-analysis (5 studies) found serratiopeptidase improved trismus more than corticosteroids (mean difference 4.42) with no difference in swelling; too few studies allowed conclusions on other outcomes or comparators. sources |
| Serrapeptase | C | Anti-inflammatory and pain-relief use overall. A 2013 systematic review (24 clinical studies) found the evidence rests on studies of poor methodology, with only a few small, usually placebo-controlled RCTs, and judged it insufficient to support use as an analgesic or health supplement. sources |
| Spearmint | C | Knee osteoarthritis pain. In a 16-week randomized trial (62 enrolled), high-rosmarinic-acid spearmint tea reduced pain from baseline but a commercial spearmint tea did not; both teas improved stiffness and physical disability. sources |
| Sweet wormwood | C | Hip and knee osteoarthritis pain. Pilot RCT (42 patients, 12 weeks): 150 mg extract twice daily improved WOMAC and pain scores from baseline; 300 mg twice daily and placebo did not. Authors called for further studies. sources |
| Tocotrienols | C | Inflammation and oxidative-stress markers. A 2021 meta-analysis (19 RCTs reviewed, 13 pooled) found lower CRP, attributed to a single delta-tocotrienol study, and no effect on IL-6, TNF-alpha or malondialdehyde. sources |
| Turmeric (and curcumin) | C | Knee osteoarthritis pain (topical ointment). NCCIH states it is unclear whether topical curcumin ointment affects knee osteoarthritis pain. sources |
| Undenatured type II collagen | C | Exercise-related knee discomfort in healthy adults. In an RCT of 55 healthy adults, 40 mg/day for 120 days improved knee extension versus placebo (81.0° vs 74.0°; p = 0.011); time exercised before joint discomfort lengthened versus baseline. sources |
| Undenatured type II collagen | C | Knee flexibility in healthy adults with activity-related joint discomfort. In a multicenter RCT of 96 adults, 40 mg/day for 24 weeks increased knee flexion range of motion versus placebo (3.23° vs 0.21°; p = 0.025). sources |
| Undenatured type II collagen | C | Joint function in healthy adults with activity-related discomfort (180 days). In an RCT of 74 healthy adults, KOOS joint-function scores improved in both the native type II collagen and placebo groups by day 180; improvements from baseline appeared earlier with the collagen. sources |
| Chaga | D | Inflammation and pain. Anti-inflammatory effects were seen in colitis models in mice, and pain-relieving effects in cell and animal studies; not studied in people. sources |
| Glucosamine and chondroitin | X | Hip osteoarthritis (glucosamine sulfate). A 2-year trial in 222 participants found glucosamine sulfate no better than placebo for pain, function or joint-space narrowing. sources |
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.